ArrowMark Colorado Holdings’s Cardiovascular Systems, Inc. CSII Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-741,523	Closed	-$10.1M	–	333
2022 Q4	$10.1M	Buy	741,523 +70,444	+10%	+$981K	0.12%	145
2022 Q3	$9.3M	Sell	671,079 -21,085	-3%	-$313K	0.11%	158
2022 Q2	$9.94M	Sell	692,164 -64,481	-9%	-$1.12M	0.11%	162
2022 Q1	$17.1M	Buy	756,645 +43,944	+6%	+$853K	0.15%	132
2021 Q4	$13.4M	Buy	712,701 +185,343	+35%	+$4.95M	0.11%	160
2021 Q3	$17.3M	Sell	527,358 -12,890	-2%	-$481K	0.14%	139
2021 Q2	$23M	Sell	540,248 -691	-0.1%	-$27K	0.17%	124
2021 Q1	$20.7M	Buy	540,939 +8,924	+2%	+$380K	0.16%	129
2020 Q4	$23.3M	Sell	532,015 -20,198	-4%	-$760K	0.18%	115
2020 Q3	$21.7M	Sell	552,213 -46,727	-8%	-$1.51M	0.21%	100
2020 Q2	$18.9M	Buy	+598,940	New	+$22.4M	0.2%	102

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

ArrowMark Colorado Holdings's CSII Position: Q1 2023 in Review

ArrowMark Colorado Holdings sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 741,523 shares — an estimated $10.1M sold.

ArrowMark Colorado Holdings first reported a position in CSII in Q2 2020 and held it in 11 quarters. The position peaked at $23.3M in Q4 2020. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

ArrowMark Colorado Holdings reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
ArrowMark Colorado Holdings sold 741,523 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $10.1M.
ArrowMark Colorado Holdings first reported a position in Cardiovascular Systems, Inc. in Q2 2020 and held it in 11 quarters.
ArrowMark Colorado Holdings's Cardiovascular Systems, Inc. position peaked at $23.3M in Q4 2020.
150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2023, filed 15 May 2023.